{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 136,
  "pageCount": 239,
  "prevPage": 135,
  "nextPage": 137,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses highlighted quotes to emphasize negative sentiment from industry experts.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/136",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-136",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The feedback was equally devastating whether from current Nevro users, former high volume Nevro implanters, or other KOL's.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b341-e692ec9dd8ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.62
      },
      "kind": "list",
      "text": "One of Nevro’s highest volume implanters, and a consultant who receives significant payments from the company, dismissed Omnia as cannibalizing existing Nevro users without gaining new ones",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57dd5405-781b-4421-bffb-c125d2e8a222",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "A KOL and former high volume Nevro user slammed Omnia’s claims of special waveforms, deriding it as a me-too device with nothing “brand new or innovative.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "925051ef-7abb-433e-b5a7-79d02035dd14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.43
      },
      "kind": "list",
      "text": "One of the highest volume implanters in New York, who still uses some Nevro, hasn’t bothered to try Omnia, calling it “incremental” with no effect on his share",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe712cb2-fffb-4575-b96f-a557e57ab339",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "The feedback was equally devastating whether from current Nevro users, former high volume Nevro implanters, or other KOL's.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2bded92-aed7-493c-958f-4b959438cc7e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.1,
        "y": 0.26
      },
      "kind": "quote",
      "text": "They try to call Omnia a high-frequency tonic [low frequency stimulation] which is bullshit. It's the same thing. They try to claim that they have burst which is also like a high-frequency burst. Bullshit. There's no data. They never did a study. Omnia is what everyone else's device can already do, just packaged in a little Nevro box. If a doctor already left Nevro because their device sucks, there's nothing Omnia does that's brand new or innovative that you can't do with whatever company you already use.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3debfcd7-48f3-4fc0-adcb-eb64cfe5882a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.1,
        "y": 0.49
      },
      "kind": "quote",
      "text": "I haven't implanted the Omnia. It's an incremental benefit. It will be better than Senza. I don't think it'll be a game changer. It won't bump my Nevro share any more. Every stim company comes up with a new device every couple of years. It's an incremental, evolutionary advancement. Not revolutionary.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fec0682-a2a6-486a-b84b-b2558b92165b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.85,
        "x": 0.1,
        "y": 0.68
      },
      "kind": "quote",
      "text": "The impact of Omnia is incremental. I think it's incremental for the Nevro users that were concerned about Nevro's limitations and therefore gave some cases to other companies. I don't know how much it gains new doctors. By now you've either used Nevro or you haven't. They're not really converting people from other companies all of a sudden because of the Omnia. They've almost exclusively converted over the previous Senza and Senza 2 users to Omnia but at the same time, I don't think it's a as big of a leap as the first time around with HF10 versus paraesthesia-based stim.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "852b4e93-0dd4-4786-93ca-94e26372e970",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"They try to call Omnia a high-frequency tonic [low frequency stimulation] which is bullshit. It's the same thing. They try to claim that they have burst which is also like a high-frequency burst. Bullshit. There's no data. They never did a study. Omnia is what everyone else's device can already do, just packaged in a little Nevro box. If a doctor already left Nevro because their device sucks, there's nothing Omnia does that's brand new or innovative that you can't do with whatever company you already use.\" — KOL and former high volume Nevro implanter; \"I haven't implanted the Omnia. It's an incremental benefit. It will be better than Senza. I don't think it'll be a game changer. It won't bump my Nevro share any more. Every stim company comes up with a new device every couple of years. It's an incremental, evolutionary advancement. Not revolutionary.\" — High volume implanter; \"The impact of Omnia is incremental. I think it's incremental for the Nevro users that were concerned about Nevro's limitations and therefore gave some cases to other companies. I don't know how much it gains new doctors. By now you've either used Nevro or you haven't. They're not really converting people from other companies all of a sudden because of the Omnia. They've almost exclusively converted over the previous Senza and Senza 2 users to Omnia but at the same time, I don't think it's a as big of a leap as the first time around with HF10 versus paraesthesia-based stim.\" — KOL and high volume Nevro implanter and consultant",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b341-e8bc96a18e12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.05,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74e2cb46-fb25-4fb4-83d8-f5550881c3c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.9,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aed39e7e-6ab5-4b6b-9fbb-ca88f10d1396",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "433833d6-be2b-43d0-8796-206a1014d1c3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}